Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-28T14:55:22.739Z Has data issue: false hasContentIssue false
  • English
  • Français

Actual expense associated with patients with Alzheimer's disease in Colombia

Published online by Cambridge University Press:  08 June 2017

Sergio I. Prada Open the ORCID record for Sergio I. Prada [Opens in a new window] ,
Yuri Takeuchi ,
Angela M. Merchán-Galvis  and
Yoseth Ariza-Araújo
Sergio I. Prada*
Affiliation:
Centro PROESA, Universidad Icesi, Calle 18 No122-135, Cali, Colombia
Yuri Takeuchi
Affiliation:
Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No122-135, Cali, Colombia
Angela M. Merchán-Galvis
Affiliation:
Facultad de Medicina, Universidad Autónoma de Barcelona, Sant Antonio María Claret 57, Barcelona, España
Yoseth Ariza-Araújo
Affiliation:
Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No122-135, Cali, Colombia
*
Correspondence should be addressed to: Sergio I. Prada, Director, Universidad Icesi, Centro PROESA, Calle 18 No, 122–135, Cali, Colombia. Phone: 57+1+3212092; Fax: 57+1+3212091. Email: siprada@icesi.edu.co.
Get access

Abstract

Background:

There is paucity in the level of knowledge on the actual insurer expenses associated with patients suffering with dementia in the developing world. Less is known about direct costs by severity and how costs vary because of the presence of other comorbidities.

Methods:

Using claims data from an insurer for three years, we identified patients with AD with an algorithm that takes advantage of information on age, primary diagnosis, and services and drugs provided.

Results:

Distribution by dementia stage was as follows: mild 21%, moderate 53%, severe 17%, and undetermined 9%. Expenses paid for all causes by the insurer were at least double than estimated in the literature and were increasing annually at rates higher than 30%. Also, 92% of patients have at least another chronic condition.

Conclusions:

Worldwide costs of dementia estimates maybe underestimating the actual costs to health systems in the developing world.

Keywords

developing countryAlzheimer's disease (AD)health economics
Type
Research Article
Information
International Psychogeriatrics , Volume 29 , Issue 11 , November 2017 , pp. 1835 - 1840
Copyright
Copyright © International Psychogeriatric Association 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Budson, A. E. and Solomon, P. R. (2016). Memory Loss, Alzheimer's Disease, and Dementia: A Practical Guide for Clinicians, 2nd edn. Edinburgh: Elsevier.Google Scholar
Jacobzone, S., Cambois, E., Chaplain, E. and Robine, J. (1998). Long term care services to older people, a perspective on future trends: the impact of an improved health of older persons. OECD Report No AWP 4.2. Paris.Google Scholar
Wimo, A. et al. (2016). The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimer's & Dementia, 13, 1–7. https://doi.org/10.1016/j.jalz.2016.07.150.Google Scholar
Wimo, A., Jonsson, L. and Winblad, B. (2006). An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dementia and Geriatric Cognitive Disorders, 21, 175–181. https://doi.org/10.1159/000090733.Google Scholar
Wimo, A., Jönsson, L., Bond, J., Prince, M. and Winblad, B. (2013). The worldwide economic impact of dementia 2010. Alzheimer's and Dementia, 9, 1–11. https://doi.org/10.1016/j.jalz.2012.11.006.Google Scholar
Wimo, A., Winblad, B. and Jönsson, L. (2010). The worldwide societal costs of dementia: estimates for 2009. Alzheimer's and Dementia, 6, 98–103. https://doi.org/10.1016/j.jalz.2010.01.010.Google Scholar